Journal of Virology · 2006 · 133 citations · 18 references
Life SciencesGeneticsMicrobiologyMolecular EvolutionMolecular VirologyVirologyAntiretroviral TherapyAntiviral Drug ResistanceAntiviral ResistanceFitness Costs Of ResistanceViral EvolutionViral MutationAntiviral Resistance MutationsDrug Resistance ModulationDrug Resistance MutationsMutational VariationResistance Mutation Fitness CostsResistance-associated MutationsReverse Transcriptase Inhibitor ResistanceViral Fitness Costs
It is generally accepted that the fitness cost of resistance mutations plays a role in the persistence of transmitted drug-resistant human immunodeficiency virus type 1 and that mutations that confer a high fitness cost are less able to persist in the absence of drug pressure. Here, we show that the fitness cost of reverse transcriptase (RT) mutations can vary within a 72-fold range. We also demonstrate that the fitness cost of M184V and K70R can be decreased or enhanced by other resistance mutations such as D67N and K219Q. We conclude that the persistence of transmitted RT mutants might range widely on the basis of fitness and that the modulation of fitness cost by mutational interactions will be a critical determinant of persistence.
18
Persistence of primary drug resistance among recently HIV-1 infected adults
Jason D. Barbour, Frederick Hecht, Terri Wrin et al. · AIDS · 2004 · 155 citations
Pope Kosalaraksa, Mark F. Kavlick, Victor Maroun et al. · Journal of Virology · 1999 · 127 citations · Full text